ImmuneBiotech
PrivateLast Round
Debt
Jul 8, 2026
Total Funding Raised
$165.79M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmuneBiotech is a biotechnology company that develops, markets, and commercializes therapeutically effective probiotic products designed with pharmaceutical precision to manage gastrointestinal and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneBiotech Comparables
Compare ImmuneBiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seed Health | 77% | |
| dsm-firmenich | 76% | |
| Pendulum Therapeutics | 74% |
ImmuneBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 8, 2026 | ||||
| Growth Equity | May 4, 2026 | ||||
| VC Round | Jan 20, 2021 | ||||
| Series A | Jan 24, 2019 |
ImmuneBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Growth Equity |
| RA Capital Management | Growth Equity |
| Omega Funds | Growth Equity |
| Blue Owl Capital | Growth Equity |
| OrbiMed | Growth Equity |
| Almi Invest AB | Debt |
| Novo Holdings | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 35% MoM.
- May 4, 2026
$165M round led by OrbiMed.
ImmuneBiotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmuneBiotech's valuation, stock price, and market status.
Is ImmuneBiotech a public or private company?
ImmuneBiotech is a private company.
What is the current stock price of ImmuneBiotech?
ImmuneBiotech is a private company with no public stock price. No recent secondary market data is available.
How much is ImmuneBiotech worth (valuation)?
Valuation information for ImmuneBiotech is not publicly available.
Can I buy ImmuneBiotech stock?
ImmuneBiotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmuneBiotech's last funding round?
ImmuneBiotech's most recent funding round was Debt on July 8, 2026.
Who are the main investors in ImmuneBiotech?
Key investors in ImmuneBiotech include OrbiMed.
Will ImmuneBiotech IPO soon?
No public IPO plans have been announced for ImmuneBiotech.
How can I track ImmuneBiotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmuneBiotech's secondary market activity and sign up for updates.